Logo image of CLS

CELESTICA INC (CLS) Stock Fundamental Analysis

NYSE:CLS - New York Stock Exchange, Inc. - CA15101Q2071 - Common Stock - Currency: USD

182.9  -1.83 (-0.99%)

After market: 184.12 +1.22 (+0.67%)

Fundamental Rating

6

Overall CLS gets a fundamental rating of 6 out of 10. We evaluated CLS against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the health and profitability get an excellent rating, making CLS a very profitable company, without any liquidiy or solvency issues. CLS is valued quite expensive, but it does show an excellent growth. With these ratings, CLS could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CLS had positive earnings in the past year.
In the past year CLS had a positive cash flow from operations.
Each year in the past 5 years CLS has been profitable.
CLS had a positive operating cash flow in each of the past 5 years.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

CLS's Return On Assets of 8.63% is amongst the best of the industry. CLS outperforms 89.52% of its industry peers.
CLS has a Return On Equity of 30.63%. This is amongst the best in the industry. CLS outperforms 93.55% of its industry peers.
With an excellent Return On Invested Capital value of 19.07%, CLS belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLS is in line with the industry average of 9.67%.
The 3 year average ROIC (11.43%) for CLS is below the current ROIC(19.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.63%
ROE 30.63%
ROIC 19.07%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CLS has a better Profit Margin (5.09%) than 70.16% of its industry peers.
In the last couple of years the Profit Margin of CLS has grown nicely.
CLS has a better Operating Margin (6.56%) than 69.35% of its industry peers.
In the last couple of years the Operating Margin of CLS has grown nicely.
With a Gross Margin value of 11.36%, CLS is not doing good in the industry: 76.61% of the companies in the same industry are doing better.
CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.56%
PM (TTM) 5.09%
GM 11.36%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLS is creating value.
CLS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CLS has been reduced compared to 5 years ago.
CLS has a worse debt/assets ratio than last year.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

CLS has an Altman-Z score of 5.16. This indicates that CLS is financially healthy and has little risk of bankruptcy at the moment.
CLS has a better Altman-Z score (5.16) than 76.61% of its industry peers.
The Debt to FCF ratio of CLS is 2.27, which is a good value as it means it would take CLS, 2.27 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 2.27, CLS is doing good in the industry, outperforming 76.61% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that CLS is not too dependend on debt financing.
CLS has a Debt to Equity ratio of 0.48. This is in the lower half of the industry: CLS underperforms 68.55% of its industry peers.
Even though the debt/equity ratio score it not favorable for CLS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 2.27
Altman-Z 5.16
ROIC/WACC2.21
WACC8.65%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.44 indicates that CLS should not have too much problems paying its short term obligations.
CLS has a Current ratio of 1.44. This is in the lower half of the industry: CLS underperforms 75.00% of its industry peers.
CLS has a Quick Ratio of 1.44. This is a bad value and indicates that CLS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.86, CLS is doing worse than 83.87% of the companies in the same industry.
The current and quick ratio evaluation for CLS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.86
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

CLS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.06%, which is quite impressive.
Measured over the past years, CLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 48.11% on average per year.
Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 20.52%.
The Revenue has been growing by 10.38% on average over the past years. This is quite good.
EPS 1Y (TTM)49.06%
EPS 3Y44.1%
EPS 5Y48.11%
EPS Q2Q%52.75%
Revenue 1Y (TTM)20.52%
Revenue growth 3Y19.63%
Revenue growth 5Y10.38%
Sales Q2Q%20.97%

3.2 Future

The Earnings Per Share is expected to grow by 30.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLS will show a quite strong growth in Revenue. The Revenue will grow by 18.86% on average per year.
EPS Next Y23.72%
EPS Next 2Y21.86%
EPS Next 3Y22.07%
EPS Next 5Y30.31%
Revenue Next Year13.73%
Revenue Next 2Y15.69%
Revenue Next 3Y16.45%
Revenue Next 5Y18.86%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 38.59, which means the current valuation is very expensive for CLS.
The rest of the industry has a similar Price/Earnings ratio as CLS.
When comparing the Price/Earnings ratio of CLS to the average of the S&P500 Index (26.84), we can say CLS is valued slightly more expensively.
CLS is valuated quite expensively with a Price/Forward Earnings ratio of 31.42.
CLS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.94. CLS is around the same levels.
Industry RankSector Rank
PE 38.59
Fwd PE 31.42
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CLS.
CLS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 54.48
EV/EBITDA 25.45
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CLS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CLS's earnings are expected to grow with 22.07% in the coming years.
PEG (NY)1.63
PEG (5Y)0.8
EPS Next 2Y21.86%
EPS Next 3Y22.07%

0

5. Dividend

5.1 Amount

No dividends for CLS!.
Industry RankSector Rank
Dividend Yield N/A

CELESTICA INC

NYSE:CLS (8/20/2025, 8:04:00 PM)

After market: 184.12 +1.22 (+0.67%)

182.9

-1.83 (-0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners76.87%
Inst Owner Change-2.33%
Ins Owners0.53%
Ins Owner Change0.07%
Market Cap21.04B
Analysts82.67
Price Target168.3 (-7.98%)
Short Float %4.54%
Short Ratio1.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.18%
Min EPS beat(2)6.65%
Max EPS beat(2)11.71%
EPS beat(4)4
Avg EPS beat(4)7.71%
Min EPS beat(4)1.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.8%
EPS beat(12)12
Avg EPS beat(12)9.35%
EPS beat(16)16
Avg EPS beat(16)9.16%
Revenue beat(2)2
Avg Revenue beat(2)4.95%
Min Revenue beat(2)2.5%
Max Revenue beat(2)7.4%
Revenue beat(4)3
Avg Revenue beat(4)2.89%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.06%
Revenue beat(12)11
Avg Revenue beat(12)3.55%
Revenue beat(16)13
Avg Revenue beat(16)2.92%
PT rev (1m)67.26%
PT rev (3m)77.34%
EPS NQ rev (1m)12.31%
EPS NQ rev (3m)16.45%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)7.86%
Revenue NQ rev (3m)7.86%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE 38.59
Fwd PE 31.42
P/S 1.99
P/FCF 54.48
P/OCF 38.32
P/B 11.97
P/tB 18.61
EV/EBITDA 25.45
EPS(TTM)4.74
EY2.59%
EPS(NY)5.82
Fwd EY3.18%
FCF(TTM)3.36
FCFY1.84%
OCF(TTM)4.77
OCFY2.61%
SpS92.05
BVpS15.28
TBVpS9.83
PEG (NY)1.63
PEG (5Y)0.8
Profitability
Industry RankSector Rank
ROA 8.63%
ROE 30.63%
ROCE 23.8%
ROIC 19.07%
ROICexc 21.37%
ROICexgc 28.15%
OM 6.56%
PM (TTM) 5.09%
GM 11.36%
FCFM 3.65%
ROA(3y)4.63%
ROA(5y)3.55%
ROE(3y)15.02%
ROE(5y)11.3%
ROIC(3y)11.43%
ROIC(5y)8.93%
ROICexc(3y)13.32%
ROICexc(5y)10.55%
ROICexgc(3y)18.44%
ROICexgc(5y)14.81%
ROCE(3y)14.26%
ROCE(5y)11.14%
ROICexcg growth 3Y31.4%
ROICexcg growth 5Y28.76%
ROICexc growth 3Y37.65%
ROICexc growth 5Y29.81%
OM growth 3Y24.27%
OM growth 5Y29.03%
PM growth 3Y34%
PM growth 5Y30.13%
GM growth 3Y8.03%
GM growth 5Y10.39%
F-Score7
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 2.27
Debt/EBITDA 0.99
Cap/Depr 100.49%
Cap/Sales 1.54%
Interest Coverage 17.29
Cash Conversion 64.05%
Profit Quality 71.71%
Current Ratio 1.44
Quick Ratio 0.86
Altman-Z 5.16
F-Score7
WACC8.65%
ROIC/WACC2.21
Cap/Depr(3y)94.48%
Cap/Depr(5y)73.42%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.34%
Profit Quality(3y)94.3%
Profit Quality(5y)151.44%
High Growth Momentum
Growth
EPS 1Y (TTM)49.06%
EPS 3Y44.1%
EPS 5Y48.11%
EPS Q2Q%52.75%
EPS Next Y23.72%
EPS Next 2Y21.86%
EPS Next 3Y22.07%
EPS Next 5Y30.31%
Revenue 1Y (TTM)20.52%
Revenue growth 3Y19.63%
Revenue growth 5Y10.38%
Sales Q2Q%20.97%
Revenue Next Year13.73%
Revenue Next 2Y15.69%
Revenue Next 3Y16.45%
Revenue Next 5Y18.86%
EBIT growth 1Y40.43%
EBIT growth 3Y48.65%
EBIT growth 5Y42.42%
EBIT Next Year45.93%
EBIT Next 3Y22.4%
EBIT Next 5Y28.45%
FCF growth 1Y59.55%
FCF growth 3Y20.17%
FCF growth 5Y2.76%
OCF growth 1Y45.13%
OCF growth 3Y27.84%
OCF growth 5Y6.55%